A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer

Doi, T; Yamaguchi, K; Komatsu, Y; Muro, K; Nishina, T; Nakajima, TE; Tang, R; Yang, H; Zhang, YL; Jung, AS; Ang, A; Yasui, H

Doi, T (reprint author), Natl Canc Ctr Hosp East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017; 47 (11): 1002

Abstract

To evaluate the safety (including adverse events and dose-limiting toxicities [DLTs]), tolerability, pharmacokinetics and antitumor activity of the in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索